key: cord-0890253-rxqpgdcy
authors: Xie, Jiao-jiao; Li, Bin; Xu, Rui; Du, Xian-zhi; He, Jin-zhi
title: Anti-TIF1 gamma-positive IPAF patient developed stage IVB lung squamous carcinoma in 1 year: a case report
date: 2021-06-30
journal: BMC Pulm Med
DOI: 10.1186/s12890-021-01570-y
sha: 32efcac82b339f083c6a55f37f9f5e015aef077c
doc_id: 890253
cord_uid: rxqpgdcy

BACKGROUND: Patients with connective tissue disease, such as dermatomyositis (DM), and positive anti-TIF1γ self-antibodies are commonly diagnosed with malignant tumors as a comorbidity. The relationship between anti-TIF1γ self-antibodies and existing malignant tumors has been confirmed by several reports. However, interstitial pneumonia with autoimmune features (IPAF) cases with a positive anti-TIF1γ self-antibody developing to solid malignant tumors are rarely reported now. CASE PRESENTATION: Herein, we presented an IPAF patient with anti-TIF1γ self-antibodies. No evidence of malignant tumors was found at the initial visit. However, the patient had developed stage IVB lung squamous cell carcinoma at the 1-year follow-up review. CONCLUSIONS: Altogether, this report described a rare case of IPAF patient with anti-TIF1γ self-antibodies developed to advanced lung squamous cell carcinoma in 1 year. The present case highlights more frequent imaging examinations to identify the occurrence of malignant tumors as early as possible in IPAF patients with positive anti-TIF1γ self-antibodies.

DM patients with positive anti-TIF1γ self-antibodies are commonly diagnosed with malignant tumors as a comorbidity [1] [2] [3] . The patient we reported was initially diagnosed as an IPAF case with anti-TIF1γ self-antibody. No evidence of malignant tumors was found. However, through the following visiting, we found the patient had developed stage IVB lung squamous cell carcinoma at the 1-year follow-up review. Recently, more and more rheumatologists and respiratory physicians start to pay more attention to the routine screening of solid tumors in DM patients with anti-TIF1γ self-antibody. However, the follow-up visiting of these patients with no tumor evidence in the initial screening is far from enough. Through this case report, we call for more attention to the follow-up radiologic imaging of these patients.

A 65-year-old Chinese man presented with gradually worsening cough and shortness of breath for 1 year. Throughout the course of the disease, the patient had no symptoms of hemoptysis or chest pain. He occasionally experienced dry mouth and dry eyes but no itchy skin, desquamation or joint pain. He was admitted to the respiratory department on July 19th, 2019, for further diagnosis and assessment. The patient had normal skin and mucosa, with no rash or scaling. No

*Correspondence: chongyixurui@163.com † Jiao-jiao Xie and Bin Li contributed equally to this report 1 Department of Respiratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, People's Republic of China Full list of author information is available at the end of the article special past histories and family inherited diseases were reported. Velcro rales could be heard in both lower lungs on physical examination. An initial chest CT scan was taken and indicated interstitial inflammation and fibrosis in the basal segment of the bilateral lower lobe (Fig. 1) . In lung function tests, DLCO suggested a moderate diffusion disorder (54.6 % predictive value).

The full blood count, basic metabolic panel, ECG and echocardiography were all normal in this patient. Antiendothelial cell antibody (AECA) was positive (1:100), but other vasculitis-related self-antibodies were negative. Antinuclear antibody (ANA), anti-CCP, anti-SSA, anti-SSB, Ro-52, anti-nRNP, anti-Sm, anti-Jo1, anti-PM-Scl, anti-Scl-70, and anti-dsDNA antibodies were all negative. However, the myositis antibody panel showed a positive test for the anti-TIF1γ self-antibody.

According to the patient's positive anti-TIF1γ selfantibody findings and NSIP chest CT manifestation without any clinical signs of DM, such as rash or skin lesions, we diagnosed this patient with IPAF. Subsequently, this patient underwent PET-CT scans and serum tumor marker analysis to search for evidence of potential solid tumors [4] . However, no evidence of any tumor was found. After excluding contraindications, the patient was given oral prednisone (30 mg) once a day and pirfenidone (600 mg) three times per day, respectively.

The patient's symptoms were not significantly aggravated after these treatments. However, the patient did not return to the hospital for follow-up reviews because of the COVID-19 epidemic in China at the end of 2019. Nearly 1 year later, the patient was admitted to the respiratory department on August 6th, 2020, presenting with aggravated shortness of breath over the previous 3 months. An enhanced chest CT scan showed an irregularly shaped nodule located on the anterior segment of the right upper lobe. Enlarged mediastinal lymph nodes were visible in the right hilum and mediastinum (Fig. 2) . Enhanced CT of the abdomen revealed bilateral adrenal nodules, and brain MRI revealed multiple metastatic nodules in the bilateral cerebral hemispheres (Fig. 2) . These imaging findings suggested the possibility of malignant lung tumors with multiple metastases. Following CT-guided percutaneous lung biopsy of the right lung nodule and needle aspiration of mediastinal lymph nodes under endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), this patient was definitively diagnosed with right lung squamous carcinoma with mediastinal lymph node, brain and adrenal glands metastasis (Fig. 3) . 

Transcriptional intermediary factor 1γ (TIF1γ), an E3 ubiquitin ligase family member, plays a crucial role in regulating TGF-β/Smad signaling in different cellular contexts [5, 6] . Based on its role in this signaling, studies on TIF1γ performed in the last decade have demonstrated a relationship between decreased TIF1γ and cancer [7, 8] . According to past studies, anti-TIF1γ antibodies are detected in approximately 20 % of adult DM patients [9] . Among them, 60-80 % have been diagnosed with malignant tumors as a comorbidity with DM [10] . In our reported case, the patient's symptoms and physical signs did not meet the criteria for initial diagnosis with DM, so the patient was diagnosed with IPAF. When we first detected the anti-TIF1γ self-antibody, PET-CT scanning and tumor biomarker detection were performed. However, there was no visible evidence of solid tumors. Unfortunately, the patient was diagnosed with stage IVB lung squamous carcinoma at the 1-year follow-up review, despite regular IPAF treatments. Some previous studies have also proposed the importance of follow-up chest CT in assessing the pulmonary status of ILD patients. However, they have not given the exact CT follow-up interval time [11, 12] . Based on this case, we suggest that IPAF patients with positive anti-TIF1γ self-antibodies might need more frequent imaging examinations to identify the occurrence of malignant tumors as early as possible.

Abbreviations CTD: Connective tissue disease; DM: Dermatomyositis; IPAF: Interstitial pneumonia with autoimmune features; AECA: Anti-endothelial cell antibody; EBUS-TBNA: Endobronchial ultrasound-guided transbronchial needle aspiration.

The association between TIF1 family members and cancer stemness in solid tumors

A novel case of TIF1 gamma autoantibody positive dermatomyositis associated with a non-functional pancreatic neuroendocrine tumor

Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection

The roles of TIF1gamma in cancer

Anti-TIF1-gamma autoantibodies: warning lights of a tumour autoantigen

Regulation of TGF-beta family signaling by E3 ubiquitin ligases

Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-betainduced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer

Repression of TIF1gamma by SOX2 promotes TGF-beta-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Oncogene

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer

Management of interstitial lung disease associated with connective tissue disease

Practical management of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

We thank the patient who contributed to this report, as well as the staff of each department.

The authors all cared for the patient and contributed to organizing the report. J.X and B.L drafted the case report and were responsible for the data and figures. R.X designed the report and was responsible for the intellectual content of the report. J.H and X.D performed the biopsy, data collecting and language modifying. J.H and X.D substantively revised the report. All authors read and approved the final manuscript.

Funding was provided by National Nature Science Foundation of China (No. 81500015) and the Foundation of Chongqing Medical University for COVID-19(X2821) for patient's follow-up review.

The data that support this case report are available from the corresponding author on reasonable request, since respecting the Ethics Committee to protect patient confidentiality.

This report was approved by the Ethical Committee of The Second Affiliated Hospital of Chongqing Medical University.

Written informed consent was obtained from the patient for publication of this case report and accompanying clinical data. A copy of the written consent in Chinese language is available for review by the editor of this journal.

There are no conflicts of interest to declare.